PharmSource - Catching the Next Wave: How Much Have CMOs Benefited from Biosimilars - 2018 Edition

Publisher Name :
Date: 03-Dec-2018
No. of pages: 74

PharmSource - Catching the Next Wave: How Much Have CMOs Benefited from Biosimilars - 2018 Edition

Summary

Biosimilars are drugs that are highly similar but not identical to branded "innovator" biologics: large molecule, immunogenic drugs produced from living cells. "Innovator" biologics are the first to be approved, and when their patent protection expires, biosimilars may be approved, in a similar way to small molecule branded drugs and their generics.

There are no clinically meaningful differences in quality, safety and efficacy between biosimilars and innovator biologics. The exact definition of a biosimilar varies by regulator.

Biosimilars bring competition to expensive innovator biologics and represent a cost-saving option for payers.

More than 50 biosimilars are approved in the EU, while the FDA lags behind with 17 approvals but is catching up fast. As more innovator biologics come off-patent in the near future, this will bring a huge opportunity for biosimilar companies and for biosimilar manufacturers.

Key Questions Answered

- What biosimilars are marketed in the US and EU?

- How is biosimilar manufacturing and packaging outsourced?

- What therapies are in the biosimilar pipeline?

- In what regions is biosimilar development concentrated?

- How does biosimilar manufacturing differ by molecule type?

- When will innovator biologic patents expire, allowing biosimilar development?

- What proportion of biosimilar manufacturing is kept in-house?

- How will contract analytical testing services be affected by the rise of biosimilars?

Scope

Detailed view of -

- Marketed Innovator Biologics.

- Marketed Biosimilars.

- Innovator Biologic Patent Expiries and Waves of Biosimilar Opportunity.

- Biosimilar Clinical Pipeline.

- Existing CDMO Contracts for Biosimilars for API, Dose and Packaging.

Reasons to buy

- This 74-page report gives important, expert insight you won't find in any other source. 20 tables and figures throughout the report illustrate major points and trends. This report is required reading for -

- CMO executives who must have deep understanding of the biosimilar marketplace to make strategic planning and investment decisions.

- Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.

- Pharmaceutical and Biotech companies involved in the development of innovator biologics or biosimilars.

- Investors that need a deeper understanding of the market to identify and value potential investment targets.

PharmSource - Catching the Next Wave: How Much Have CMOs Benefited from Biosimilars - 2018 Edition

Table of Contents
1. Executive Summary 4
2. Introduction 6
3. The Biosimilar Opportunity 7
4. Approved Biosimilars 10
5. Market Penetration 29
Regional Variability in Biosimilar Uptake 32
Biosimilar vs. Innovator Market Share 34
New Patient Access 35
6. The Biosimilar Pipeline 36
7. Sourcing Arrangements for Biosimilars 42
Joint Ventures 48
Capacity and scale 52
API Segmentation 52
Geography and Partnerships 53
Analytic and Testing CDMOs 54
8. Notes on Methodology 56
9. Appendix 57
9.1 Bibliography 57
9.2 Primary Research - Key Opinion Leaders in this Report 58
9.3 Additional Tables 59
9.4 About the Authors 75

List of Tables
Table 1: FDA-Approved Biosimilars and Their API Manufacturing Contracts 11
Table 2: FDA-Approved Biosimilars and Their Dose Manufacturing Contracts 13
Table 3: FDA-Approved Biosimilars and Their Packaging Contracts 15
Table 4: EMA-Approved Biosimilars and Their API Manufacturing Contracts 17
Table 5: EMA-Approved Biosimilars and Their Dose Manufacturing Contracts 21
Table 6: EMA-Approved Biosimilars and Their Packaging Contracts 25
Table 7: Waves of Biosimilar Opportunity by EU Patent Expiry of Biologic Innovators 59
Table 8: Waves of Biosimilar Opportunity by US Patent Expiry of Biologic Innovators 67

List of Figures
Figure 1: Waves of Biosimilar Opportunity by EU Patent Expiry of Innovator Biologics 8
Figure 2: Market Share Forecast by Class for UC in the US, 2016 30
Figure 3: Biosimilars in Clinical Development 37
Figure 4: Biosimilar Clinical Development by Sponsor Type 39
Figure 5: Biosimilar Clinical Development by Sponsor HQ Location 40
Figure 6: Outsourcing of Biosimilar Approvals, EU 43
Figure 7: Proportion of API Outsourcing of Biosimilar Approvals, EU, Jan. 2009-Dec. 2018 44
Figure 8: Proportion of Dose Outsourcing of Biosimilar Approvals, EU, Jan. 2009-Dec. 2018 44
Figure 9: Outsourcing of Biosimilar Approvals, US 46
Figure 10: Proportion of API Outsourcing of Biosimilar Approvals, US 46
Figure 11: Proportion of Dose Outsourcing of Biosimilar Approvals, US 47
Figure 12: Manufacturing of FDA- and EMA-Approved Biosimilars by Molecule Type 50
  • Global Decoagulant Market Research Report 2020
    Published: 27-Mar-2020        Price: US 2900 Onwards        Pages: 115
    The global Decoagulant market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Decoagulant volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Decoagulant market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Eu......
  • Global Drug Excipients Market Research Report 2020
    Published: 27-Mar-2020        Price: US 2900 Onwards        Pages: 124
    The global Drug Excipients market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Drug Excipients volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Drug Excipients market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North......
  • Global Ultra-low Molecular Weight Heparin (ULMWH) Market Research Report 2020
    Published: 27-Mar-2020        Price: US 2900 Onwards        Pages: 116
    The global Ultra-low Molecular Weight Heparin (ULMWH) market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Ultra-low Molecular Weight Heparin (ULMWH) volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Ultra-low Molecular Weight Heparin (ULMWH) market size by analysing historical data a......
  • Global Antidepressants Market Research Report 2020
    Published: 27-Mar-2020        Price: US 2900 Onwards        Pages: 91
    The global Antidepressants market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Antidepressants volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Antidepressants market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North......
  • Global Physician Dispensed Cosmeceuticals Market Research Report 2020
    Published: 27-Mar-2020        Price: US 2900 Onwards        Pages: 95
    The global Physician Dispensed Cosmeceuticals market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Physician Dispensed Cosmeceuticals volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Physician Dispensed Cosmeceuticals market size by analysing historical data and future prospect. Regi......
  • Global Sheep Placenta Extract Market Research Report 2020
    Published: 27-Mar-2020        Price: US 2900 Onwards        Pages: 119
    The global Sheep Placenta Extract market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Sheep Placenta Extract volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Sheep Placenta Extract market size by analysing historical data and future prospect. Regionally, this report focuses on sever......
  • Global Surgical Bandage Market Research Report 2020
    Published: 27-Mar-2020        Price: US 2900 Onwards        Pages: 118
    The global Surgical Bandage market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026. This report focuses on Surgical Bandage volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Surgical Bandage market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: No......
  • Global Scar Dressings Market Research Report 2020
    Published: 27-Mar-2020        Price: US 2900 Onwards        Pages: 122
    The global Scar Dressings market is valued at US$ 331.7 million in 2020 is expected to reach US$ 853.9 million by the end of 2026, growing at a CAGR of 14.3% during 2021-2026. This report focuses on Scar Dressings volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Scar Dressings market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: ......
  • Global Foam Dressings Market Research Report 2020
    Published: 27-Mar-2020        Price: US 2900 Onwards        Pages: 122
    The global Foam Dressings market is valued at US$ 431.4 million in 2020 is expected to reach US$ 2756.9 million by the end of 2026, growing at a CAGR of 30.0% during 2021-2026. This report focuses on Foam Dressings volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Foam Dressings market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions:......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs